• BX Home
  • Pharmaceutical Approvals: Blog [Page 5]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL APPROVALS

Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.

Pharmaceutical Approvals is part of Business Exchange, suggested by Evan Rappaport. This topic contains 1,740 news and 318 blog items. Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from like-minded professionals.

Blogs

Recent blog posts on this topic.

Qnexa Approved? Someone Seems To Know. . .more

People are waiting to hear the fate of Qsymia (or Qnexa?), the obesity combo therapy being developed by Vivus (fixed...

Qnexa Approved? Someone Seems To Know. . .more

People are waiting to hear the fate of Qsymia (or Qnexa?), the obesity combo therapy being developed by Vivus (fixed...

Employee Surveillance at the FDAmore

What on earth has been going on at the FDA? The agency has engaged in a large and long-running surveillance of its own...

Employee Surveillance at the FDAmore

What on earth has been going on at the FDA? The agency has engaged in a large and long-running surveillance of its own...

PhRMA Waits For The Supreme Courtmore

There's no escaping politics and health care policy today. No matter what happens to the Affordable Care Act this...

PhRMA Waits For The Supreme Courtmore

There's no escaping politics and health care policy today. No matter what happens to the Affordable Care Act this...

Shire's Replagal Problems: An Inside Look?more

If you've been following Shire Pharmaceuticals and their Replagal saga, you've had quite a few twists and turns to keep...

Shire's Replagal Problems: An Inside Look?more

If you've been following Shire Pharmaceuticals and their Replagal saga, you've had quite a few twists and turns to keep...

Roche Closes Nutley, Once Its US R&D Homemore

Big news, and unfortunate news for the New Jersey end of the pharma business: Roche is closing down their entire site...

Roche Closes Nutley, Once Its US R&D Homemore

Big news, and unfortunate news for the New Jersey end of the pharma business: Roche is closing down their entire site...

Cheer For Good Ol' Pfizer Umore

The biggest pharma companies increasingly seem to feel as if they need universities nearby. We've talked about this...

Scaling Up Arteminisinmore

A recent article in Science illustrates a number of points about drug development and scale-up. It's about artemisinin,...

Scaling Up Arteminisinmore

A recent article in Science illustrates a number of points about drug development and scale-up. It's about artemisinin,...

Return of the Rhodanomemore

I do hate to bring up rhodanines again, but I'm not the one who keeps making the things. This paper from ACS Medicinal...

Return of the Rhodanomemore

I do hate to bring up rhodanines again, but I'm not the one who keeps making the things. This paper from ACS Medicinal...

The NIH's Drug Repurposing Initiative: Will It Be a Waste?more

The NIH's attempt to repurpose shelved development compounds and other older drugs is underway: The National Institutes...

A New Way to Kill Amoebas, From An Old Drugmore

Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...

A New Way to Kill Amoebas, From An Old Drugmore

Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...

Arena and Lorcaserin, Back at the FDAmore

For those of you following Arena Pharmaceuticals and their long-running efforts to get lorcaserin approved by the FDA,...

Benlysta's Advertures In the Real Worldmore

Benlysta got approved for lupus last year, as the first new drug in the field in decades. But as noted at the time, it...

The Biotech Class of the Early 90smore

Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.

The Biotech Class of the Early 90smore

Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.

Regulatory Hurdlesmore

John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...

Regulatory Hurdlesmore

John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...

India's First Drug Isn't India's First Drugmore

There have been a number of headlines the last few days about Ranbaxy's Synriam, an antimalarial that's being touted as...

Top Sources: Pharmaceutical Approvals

  • SeekingAlpha.com: Home Page
  • DODTracker.com New Deals Feed
  • stockerblog.blogspot.com
  • What's New at CBER
  • RSS from PharmiWeb.com
  • futurebiopharma.blogspot.com
  • In the Pipeline
  • FDA Law Blog
  • Health News from Medical News Today
  • Medical Device Recalls since November 11, 2009

Most Active Users in this Topic

see all contributors in Pharmaceutical Approvals

Featured White Papers

Post a Job

Jobs in this Topic

Director, Downstream Development - Drug Substance & Drug Product Boehringer Ingelheim | Fremont, CA
Posted: May 9
Associate Director, Drug Regulatory Affairs Product Group Boehringer Ingelheim | Connecticut
Posted: May 19
Pharmaceutical Sales Specialist - CC PC1 AstraZeneca | Whittier, CA
Posted: May 22
Pharmacy Technician (Oncology & Investigational Drugs) United States Department of Veterans Affairs | Reno, NV
Posted: May 21
Senior Pharmaceutical Sales Specialist (San Diego/Orange County, CA) Shire Pharmaceuticals | Field, KY
Posted: May 18

Report comment contains invalid characters. ()
cancel
Search Cancel